Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional)
The summary for the Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional): The purpose of this notice of funding opportunity (NOFO) is to support applications from small businesses to develop solutions for commercialization that enable regional genomic medicine eConsult Service.
Federal Grant Title: | Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-24-106 |
Type of Funding: | Grant |
CFDA Numbers: | 93.172 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | May 30th, 2024 |
Original Application Deadline: | May 30th, 2024 |
Posted Date: | January 9th, 2024 |
Creation Date: | January 9th, 2024 |
Archive Date: | July 5th, 2024 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | January 9th, 2024 |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/pa-files/PAR-24-106.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/U...
- • ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/U...
- • Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
- • Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required)
- • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
- • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
- • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
- • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
- More Grants from the National Institutes of Health
- • ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/U...
- • ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/U...
- • Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01...
- • Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01...
- • Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Cli...